Trial Profile
Phase II study of metronomic oral Vinorelbine plus Bevacizumab as first line treatment for metastatic breast cancer patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 23 Jun 2011 New trial record